Riskpilot← Back to searchSign inGet full accessDr. Gardell & Partners AB
ABBankruptOrg 5567916480Photographic activities · NACE 7420Est. 20090 employees
Revenue 2020
SEK 13K
EBITDA margin
-584.6%
-7500% vs 2019
Equity ratio
1.7%
Financial strength
Net profit 2020
SEK -76K
-7500% vs 2019
| Revenue | SEK 13K | — |
| EBITDA | SEK -76K | -7500% |
| Net profit | SEK -76K | -7500% |
| Total assets | SEK 293K | +257% |
| Equity | SEK 5K | -94% |
| Employees | 0 | — |
Legal name
Dr. Gardell & Partners AB
Org number
5567916480
Legal form
Aktiebolag
NACE code
7420 · Photographic activities
Founded
27 oktober 2009
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-06-30
Financial year
January – December
Company purpose
Bolaget skall bedriva hudvård och skönhetsverksamhet, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 185 | 11 | 0 | 0 | 13 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 58 | −10 | −7 | −1 | −76 |
| Depreciation & amort. | −28 | −0 | −0 | −0 | −0 |
| EBIT | 30 | −10 | −7 | −1 | −76 |
| Net financials | — | — | — | — | — |
| Profit before tax | 70 | −10 | −8 | −1 | −76 |
| Tax | −16 | −0 | −0 | −0 | −0 |
| Net profit | 54 | −10 | −8 | −1 | −76 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 448 | 102 | 82 | 82 | 293 |
| Equity | 227 | 90 | 82 | 81 | 5 |
| Long-term debt | 165 | 9 | 0 | 1 | 285 |
| Short-term debt | 56 | 4 | 0 | 0 | 2 |
| Total debt | 221 | 13 | — | 1 | 287 |
EBITDA margin
-584.6%
This company
15.8%
Market median
-3800% vs market
20162020
Equity ratio
1.7%
This company
38.2%
Market median
-96% vs market
20162020
Return on equity
-1520.0%
This company
18.4%
Market median
-8361% vs market
20162020
Net profit margin
-584.6%
This company
8.1%
Market median
-7317% vs market
20162020
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20162020
Debt / equity
57.60×
This company
0.62×
Market median
-9190% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Gardell & Partners AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rebecka Ann-Christine Ahlam Gardell | Board of Directors | 0 companies |
| Rebecka Ann-Christine Ahlam Abu Asba Gardell | Board of Directors | 0 companies |
| Shaker Abu Asba | Deputy Board Member | 0 companies |